Tag:
Spencer Pharmaceutical
Latest Headlines
Latest Headlines
Spencer board OKs buyout
Spencer Pharmaceutical announced today that its board of directors is in favor of the buyout offer at $0.97 per share. The company has requested details from the acquirer as well as timeline and have
Spencer, National Pharma develop CNS treatments
Spencer Pharmaceutical is combining its oral drug delivery system with National Pharmaceutical Corp. and, together, will develop treatments for central nervous system diseases like Alzheimer's and
Spencer develops metformin for diabetics without GI side effects
Those who suffer from Type 2 diabetes know that the treatment can feel worse than the disease. The most debilitating side-effect, and one that often presents a major barrier to patient compliance, is
